Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A and intensive rehabilitation for upper limb function in children with hemiparetic cerebral palsy
2006-002175-40Phase 3Active
- Start
- May 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of botulinum toxin type A in Congenital Hemiplegia (4 arms). Primary endpoints: Activity-level upper limb function and skills and Randomized factorial comparison of four treatment strategies. Started May 2006; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
Congenital Hemiplegia
Beyond the preview
Go deeper on 2006-002175-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002175-40.